Microbix Biosystems reports FQ3 results

1 hour ago 1

Microbix Biosystems press release (OTCQX:MBXBF): FQ3 revenue was $3.5M, a 31% decrease from a year ago.
Q3 gross margin percentage was 41%, down from 54% last year.
Overall, lower Q3 revenues, weaker margins and higher operating expenses led to a net loss of $1.6M versus Q3 2024 net income of $246,746.
Cash used in operating activities was $1,923,694, compared to cash provided of $604,064 in Q3 2024.

Recommended For You